Technical Analysis for PFE - Pfizer, Inc.

Grade Last Price % Change Price Change
grade D 36.55 -0.14% -0.05
PFE closed down 0.14 percent on Thursday, November 14, 2019, on 1.31 times normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Flat Down
See historical PFE trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Stochastic Reached Oversold Weakness 0.00%
Inside Day Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Fell Below 50 DMA Bearish -0.14%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.14%
Outside Day Range Expansion -1.14%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.03%
Narrow Range Bar Range Contraction -1.03%
NR7 Range Contraction -1.03%

Older signals for PFE ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. Its Primary Care segment offers human prescription pharmaceutical products primarily prescribed by primary-care physicians for Alzheimer's disease, cardiovascular, erectile dysfunction, genitourinary, major depressive disorder, pain, respiratory, and smoking cessation therapeutic and disease areas. The company's Specialty Care and Oncology segment provides human prescription pharmaceutical products for anti-infectives, endocrine disorders, hemophilia, inflammation, ophthalmology, pulmonary arterial hypertension, specialty neuroscience, and vaccines, as well as oncology and oncology-related illnesses. Its Established Products and Emerging Markets segment offers human prescription pharmaceutical products that have lost patent protection or marketing exclusivity in certain countries and/or regions, as well as that are sold in emerging markets, including Asia, Latin America, the Middle East, Eastern Europe, Africa, Turkey, and Central Europe. The company's Animal Health segment offers products and services to prevent and treat disease in livestock and companion animals, including anti-infectives, vaccines, parasiticides, medicinal feed additives, other pharmaceutical products, and other non-pharmaceutical products. Its Consumer Healthcare segment provides non-prescription products in therapeutic categories, such as dietary supplements, pain management, respiratory, and personal care. The company sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. has a strategic collaboration with CytomX Therapeutics, Inc. to develop and commercialize Multiple Probody drug conjugates in oncology. The company was founded in 1849 and is headquartered in New York, New York.
Biopharmaceutical Health Pharmaceutical Industry Pain Disease Medication Pharmaceutical Products Inflammation Neuroscience Alzheimer's Disease Pain Management Cnx Nifty Dietary Supplements Pulmonary Arterial Hypertension Major Depressive Disorder Hemophilia Anti Infectives Pfizer Erectile Dysfunction Glaxosmithkline Livestock Producers Cardiovascular Endocrine Disorders Lupin Limited Non Pharmaceutical Products
Is PFE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 46.47
52 Week Low 33.97
Average Volume 18,272,923
200-Day Moving Average 39.9449
50-Day Moving Average 36.6268
20-Day Moving Average 37.2075
10-Day Moving Average 37.252
Average True Range 0.5511
ADX 16.73
+DI 20.1307
-DI 24.2724
Chandelier Exit (Long, 3 ATRs ) 37.2867
Chandelier Exit (Short, 3 ATRs ) 37.8733
Upper Bollinger Band 38.6297
Lower Bollinger Band 35.7853
Percent B (%b) 0.27
BandWidth 7.644695
MACD Line 0.0935
MACD Signal Line 0.2538
MACD Histogram -0.1603
Fundamentals Value
Market Cap 217.38 Billion
Num Shares 5.95 Billion
EPS 1.37
Price-to-Earnings (P/E) Ratio 26.68
Price-to-Sales 4.06
Price-to-Book 3.64
PEG Ratio 2.40
Dividend 1.28
Dividend Yield 3.50%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 37.21
Resistance 3 (R3) 37.21 36.98 37.10
Resistance 2 (R2) 36.98 36.82 36.99 37.06
Resistance 1 (R1) 36.77 36.71 36.66 36.77 37.03
Pivot Point 36.54 36.54 36.49 36.55 36.54
Support 1 (S1) 36.33 36.38 36.22 36.33 36.07
Support 2 (S2) 36.10 36.27 36.11 36.04
Support 3 (S3) 35.89 36.10 36.00
Support 4 (S4) 35.89